ABSTRACT. A female infant who died 2.5 d after birth with hypoglycemia, lactic acidosis, and sudden multisystem failure was studied. Biochemical studies showed complex 111 and IV deficiency in liver, kidney, and muscle, with muscle most severely affected. Southern blot analysis of the patient's mitochondrial DNA did not reveal any deletions. Denaturing gradient gel analysis, which detects single base changes by differences in melting behavior, showed an extra band that was not seen in mitochondrial DNA from the mother, the mother's identical twin sister, or an unrelated normal subject. This extra band indicated heteroplasmy for a restriction fragment containing the apocytochrome b and transfer RNAthr genes. Sequencing revealed an A to G mutation at nucleotide 15923, the last base of the anticodon loop of the transfer RNAth' gene. The mutation lengthens the anticodon stem by added pairing and reduces the anticodon loop size from 7 to 5 nucleotides, potentially compromising transfer RNAth function in translation and/or in processing the polycistronic RNA transcript. The patient's mother previously had a male infant who also died at 1.5 d postnatal, and both the mother and her twin have had multiple miscarriages. Amniocentesis for a genetic screen was performed on the mother's twin sister during a recent pregnancy; some of the cultured cells were made available for this study. The mutation was not found in the amniocytes or in umbilical cord blood obtained at birth; the baby was normal at birth and remains healthy. It is concluded that the mutation at nucleotide 15923 was most likely the cause of the fatal disease in the index case. The timing of the illness was consistent with postnatal depletion of glycogen reserves. The findings suggest that a mitochondrial disorder should be considered for infants who experience sudden cardiopulmonary arrest within the first few days of life. (Pediatr Res 33: 433-440, 1993) Abbreviations mtDNA, mitochondrial DNA FIMED, fatal infantile mitochondrial enzyme deficiency nt, nucleotide DGGE, denaturing gradient gel electrophoresis DHU, dihydrouridine PCR, polymerase chain reaction MBP, melting behavior polymorphism tRNA, transfer RNA
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The mitochondrial respiratory chain is composed of four enzyme complexes: complex I (NADH-CoQ oxidoreductase), complex I1 (succinate-CoQ oxidoreductase), complex I11 (CoQcytochrome c oxidoreductase), and complex IV (cytochrome c oxidase). The ATP synthetase is complex V. Most respiratory chain defects that manifest clinically occur in respiratory complexes I, 111, and IV (1-5); defects in I1 and V have been reported less frequently. A deficiency of mitochondrial respiratory enzyme activity is the cause of the fatal infantile form of mitochondrial disease, FIMED. A commonly reported form of FIMED is characterized by a myopathy that includes generalized muscle weakness and lactic acidosis with primary or secondary encephalopathy. Some patients have instead, or in addition, hepatopathy, renal dysfunction, and cardiomyopathy. They all usually die before 1 y of age, especially if muscle is involved and if the defect involves cytochrome c oxidase in any of the affected tissues, although reversible courses have been described in a few patients (5).
Deletions and point mutations in mtDNA have been reported in a number of mitochondrial diseases (5, 6). Many cases of Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia, Pearson's syndrome, and unclassified mitochondrial myopathies are associated with large deletions of the mitochondrial genome (5). Leber's hereditary optic neuropathy is related to several point mutations in respiratory complexes I and I11 (7, 8). A mutation in the ATPase subunit 6 gene has been found in another mitochondrial disease (9). At the time of a recent review ( 9 , 17 mitochondrial tRNA point mutations in 11 different tRNA had been found in various mitochondrial disorders. Specific mutations in certain mitochondrial tRNA occur with high frequency in maternally inherited, progressive syndromes such as myoclonus epilepsy and ragged red fibers and mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.
No clear pattern has been established for the cause of FIMED, which comprises a large subset of mitochondrial diseases. The disease is clinically variable depending on which organ dysfunction dominates the picture, and there may be various genetic causes (5). The common endpoint is failure to develop independent aerobic metabolism in newborn life. We previously reported two novel A to G mutations, one in the anticodon stem and one in the anticodon loop of the mitochondrial tRNAth' gene, in two unrelated patients with FIMED who died 2 to 4 d after birth (10). The latter case was an unusual form of FIMED, in that the infant appeared normal before sudden cardiopulmonary arrest on d 2 of life. The purpose of this article is to describe the clinical, biochemical, and molecular features of this case in greater detail and to report an extension of the mtDNA analysis to family members and to amniocentesis. The findings specifically suggest a causative role for the mitochondrial tRNAthr mutation in this patient's illness and more generally suggest that a mitochondrial disorder should be considered when precipitous multisystem failure occurs in early postnatal life.
MATERIALS AND METHODS
Patient description. The index case was a full-term female weighing 3.2 kg, born to a 37-yr-old woman who was in good health. The baby had an uncomplicated, normal, spontaneous vaginal delivery with Apgar scores of 9 and 9 and was asymptomatic for the first 24 h. She was examined by a cardiologist who found no abnormalities. On the 2nd d, the mother noticed that the baby had a progressively weak suck and became dusky after the last feeding. At 34 h, she had a sudden respiratory and cardiac arrest, and cardiopulmonary resuscitation was started immediately. She remained in cardiopulmonary arrest intermittently with ongoing cardiopulmonary resuscitation for 2.5 h, at the end of which time there was a sinus rhythm, and she opened her eyes. A transport team found the baby with a heart rate of 180 beats/min; she was hypoglycemic (30 mg/dL), and her pupils remained dilated and fixed. The baby was transferred to Massachusetts General Hospital and was stabilized on supported respiration. Serum potassium was 8.8 mmol/L (normal 4 to 6 mmol/L). Serum lactate was 5.0 nmol/L (normal 0.6 to 1.8 nmol/L); plasma ammonia was 99 pmol/L (normal 12 to 55 pmol/L); total plasma carnitine was 57.6 pmol/L (normal 26 to 67 pmol/L); free/total carnitine was 18% (normal 70 to 94%). A urine screen revealed very high lactate, slightly elevated 3-OHbutyrate, and an unremarkable amino acid pattern. She was treated with K-exylate, bicarbonate, triple pressors, and glucose.
She subsequently required defibrillation twice but had recurrent ventricular tachycardia and then ventricular fibrillation. She was defibrillated again without recovering sinus rhythm. Finally, the patient became asystolic and was pronounced dead at 56 h of age.
General pathology was unremarkable. Ultrastructural examination of autopsy tissues showed that liver and skeletal muscle were in a moderately preserved state. Mitochondria were qualitatively unremarkable in number, size, morphology, and intracellular distribution, and were judged to be within normal ultrastructural limits.
Family history. The mother's history was notable for five spontaneous abortions and for a male child who died in cardiopulmonary arrest at about 42 h of life. He was born after an uncomplicated pregnancy and normal spontaneous vaginal delivery with Apgar scores of 9 and 9. His birth weight was 2.9 kg. At 30 h, he was found apneic in the newborn nursery. He was initially stabilized, but enroute to a medical center he had a cardiopulmonary arrest. He was pronounced dead after 3 h of resuscitation efforts, including defibrillation. The pathology report noted structural abnormalities in the aorta and aortic valve that were consistent with mild congenital heart disease, but the course of events was identical to that of the sibling who is the index case, and metabolic disease was a question at the time. Newborn blood spots required for organic acid screening can be used for mtDNA analysis, but the boy's blood sample was not obtained because of his sudden decline and transfer to another facility.
The mother has an identical twin sister who also has had several miscarriages. At about the time that we were concluding studies on the index case, the mother's twin became pregnant. Amniocentesis was performed in the 1st trimester for various genetic screens, and extra cultured cells were available for studies of fetal mtDNA.
Suspicion of mitochondrial disease. Metabolic disease, possibly mitochondrial, was investigated in the index case due to a combination of factors, including: I ) a sibling with identical course; 2) fulminant illness without infection or other explanation; 3) elevated lactate, hypoglycemia, and low free/total carnitine ratio; and 4) cardiac arrest and multisystem failure consistent with a time course for postnatal glycogen depletion.
Biochemical analysis. All tissues used in this study were available retrospectively, as remainders from tissues obtained for unrelated pathologic, diagnostic, or surgical/medical purposes. The studies were reviewed and approved on this basis by the Human Studies Committee. For the patient, frozen autopsy tissue was used. Controls were autopsy, biopsy, or surgical tissues that were stored at -70°C from children and young people without evidence of mitochondrial disease. Homogenates and mitochondrial membrane fractions were prepared from frozen liver, kidney, and muscle, as described previously (1 1). Enzyme activities were assayed spectrophotometrically according to standard methods. Citrate synthetase, a matrix marker enzyme (12), was assayed in homogenates to assess tissue integrity. Succinate-cytochrome c reductase activity, which includes respiratory complex I1 and I11 activities, and cytochrome c oxidase activity, which is complex IV, were assayed to assess respiratory chain function (1 3). Complex I activity was not measured in this patient. Among the controls, there was no significant difference in measured enzyme activities between autopsy and biopsy/ surgical samples (data not shown), so they were treated as one group.
Southern blot analysis ofpatient's mtDNA. Total cellular DNA was isolated by standard methods from frozen tissues (14). To determine the abundance of mtDNA relative to nuclear DNA, 5 to 10 pg of each DNA sample were digested with PvuII, electrophoresed through an 0.8% agarose gel, and transferred to a nitrocellulose filter. The filter was then hybridized with total human linearized mtDNA and a I .O-kb EcoRI-BamHI fragment of human 18s rRNA gene (kindly provided by Dr. Simon Waters, University of Massachusetts) that was 32P-labeled by random priming as previously described (1 5).
Hybridization was performed overnight at 65°C in a solution containing 10 x Denhardt's solution, 5 x standard saline citrate, 1 % SDS, and 100 pg/mL denatured salmon sperm DNA. Filters were washed three times for 30 min in a solution containing 1 x standard saline citrate and 1 % SDS at 65°C. Films were exposed for 8 h. Before each subsequent hybridization, the probe was removed by boiling the filter in water for 10 min.
Extraction of total DNA from relatives' blood and umbilical cord blood for mtDNA analysis. Ten mL of blood were obtained from the mother, the mother's twin sister, and her child's umbilical cord. Total DNA was extracted from buffy coats using standard procedures as follows. The cells were lysed with SDS, digested with proteinase K, extracted with phenol followed by chloroform:isoamyl alcohol (24: I), and finally precipitated with ethanol. This crude total DNA was then resuspended in TE buffer (10 mM Tris-HC1, pH 8.0; 1 mM EDTA).
Extraction of total DNA from cultured amniocytes. Cells cultured from amniocentesis were harvested by adding fresh 0.25% trypsin and centrifuging for 15 min at 500 x g. After the cells were washed with ice-cold PBS, they were resuspended with lysis buffer (100 mM NaCl; 10 mM Tris-HC1, pH 8.0; 25 mM EDTA, pH 8.0; 0.5% SDS; and 0.1 mg/mL proteinase K) and incubated at 37°C with shaking for 3 h in tightly capped tubes. After a 3-h incubation, samples were extracted with an equal volume of phenol. DNA was precipitated by the addition of 2 vol of 100% ethanol in the presence of 0.2 vol of 10 M ammonium acetate. The yield of DNA/25-cm2 culture flask was about 60 pg.
Analysis of patient liver and muscle mtDNA by DGGE. mtDNA was isolated from mitochondrial fractions that were prepared from frozen autopsied liver and muscle. Twenty-ng aliquots of mtDNA were digested separately with DdeI, HaeIII, HphI, and MboII. The mtDNA fragments were analyzed by DGGE as previously described (15). Briefly, fragments were electrophoresed in a 6.5% acrylamide gel with a 30 to 70% denaturant range (100% denaturant = 7 M urea/40% formamide) for 18 h at 65 V. After DGGE, the gel was electroblotted onto a nylon membrane and hybridized with 32P-labeled human mtDNA clones. The region of the patient's mtDNA corresponding to clone 13 and containing the fragment that migrated differently than control fragments on the same gel was amplified from total DNA by PCR using the primers described below, subcloned, and sequenced as previously described (15). Both strands were sequenced from two different batches of PCR products to confirm the presence of the mutation.
Digestion with AccI to detect the mtDNA mutation in tRNAth'. A DNA fragment corresponding to mitochondrial clone 13 (10) (nt 14956-16053), covering apocytochrome b and tRNAthr, was amplified by PCR from 200 ng of total DNA using two primers: primer A: 5' 16085 GCGGTTGTTGATGGGTGAGT 16066 3'; primer B: 5 ' 14947 CCACATCACTCGAGACGTAA 14966 3'. The amplified DNA fragment was digested with AccI, electrophoresed in a 1 % agarose gel, and transferred to a nitrocellulose filter by Southern blotting. The filter was hybridized with 32P-labeled mitochondrial clone 13 and exposed to x-ray film for 8 h (15).
Computer analyses of nucleic acid structure. The human tRNAthr gene sequence was compared for homology with the published sequence of cow, rat, mouse, Xenopus laevis, Drosophila yakuba, and two species of sea urchin (1 6-18).
The Zucker program PCFOLD was used to determine probable differences in the secondary structure of the wild type and mutant sequences of the tRNAthr anticodon loop.
RESULTS
Biochemistry. Table 1 shows reduced succinate cytochrome c reductase activity (6% of control) and cytochrome c oxidase activity (5% of control) in mitochondrial membranes prepared from the patient's skeletal muscle. These apparent enzyme deficiencies were not an artifact of differential centrifugation, inasmuch as cytochrome c oxidase activity was decreased to the same extent in whole homogenates (8% of control) as in the mitochondrial fraction. The lower citrate synthetase activity in the homogenate (41 % of control) may reflect loss of tissue integrity, but it could also be due to fewer mitochondria in the patient's muscle. Nevertheless, the citrate synthetase result suggests that the reduced respiratory enzyme activities cannot be attributed entirely to possible loss of tissue integrity, because citrate synthetase activity was decreased to a much lesser extent than the respiratory enzyme activities.
In liver mitochondrial membranes, succinate cytochrome c reductase activity was not detectable, and cytochrome c oxidase activity was decreased to 37% of control (Table I) . Cytochrome c oxidase was decreased to the same extent in liver homogenate (35% of control). However, for liver, citrate synthetase was decreased to 44% of control. Therefore, by the same arguments used above for muscle, some of the decrease in cytochrome c oxidase activity might be attributable to loss of tissue integrity. Nevertheless, it is clear that the decrease in succinate cytochrome c reductase activity is an actual deficiency.
For kidney, the data are not as complete, but the respiratory enzyme deficiency does follow the same pattern as seen in liver, in that succinate cytochrome c reductase activity was reduced to a greater extent than cytochrome c oxidase activity (Table 1) .
Southern blot analysis of mtDNA. By Southern blot analysis of PvuII-digested DNA, no noticeable differences such as deletions or duplications between affected and unaffected subjects in the same maternal line were found when total mtDNA was used as a probe for the mtDNA signal (Fig. IA) . Because mtDNA depletion was reported as one of the causes of FIMED (19), we looked for a quantitative change of mtDNA in this patient. The same genomic blot of PvuII-digested total DNA was hybridized with a nuclear 18s rRNA gene probe after stripping the mitochondrial probe from the filter (Fig. 1B) . The ratio of mtDNA to nuclear DNA can be estimated by comparing Figure 1A and B. The mother's twin sister, the mother, and the patient all had ratios that were different from an unrelated control but similar to each other. This similarity between the patient and her phenotypically normal relatives rules out mtDNA depletion as a specific cause of the fatal disease in this infant. By electron microscopic study, there was no remarkable morphology or distribution of mitochondria in liver and muscle (data not shown).
Identification of tRNAthr mutation. By DGGE (1 5), we found an MBP among HphI fragments (shown by the arrow in Fig. 2B ) that were probed with mtDNA clone 13 ( Fig. 2A) . This clone covers a portion of the cytochrome b coding region, the tRNAthr gene, and a portion of the D loop ( Fig. 2A) . With this probe, an extra band just below the major band was detected in the patient but not in the control and not in the mother's twin sister or the mother. This indicates that the patient had both wild type and mutant mtDNA existing in a heteroplasmic state (Fig. 2B) .9 Fig. 1 . Southern blot analysis of mtDNA. Total DNA was extracted from normal control liver, patient muscle, and blood from the mother and the mother's twin sister. The total DNA was digested with PvuII, electrophoresed through a 0.8% agarose gel, transferred to nitrocellulose, and hybridized with 32P-labeled total human mtDNA (A) and a 32P-labeled human 18s rRNA clone (B).
can be seen in Figure 2B , it was necessary to overexpose the film to demonstrate the extra band clearly. Because the bands were so close together and because the labeled wild type fragment had saturated the film, it was not possible to quantitate the extent of heteroplasmy by scanning densitometry.
We examined other regions of mtDNA using additional mitochondrial clones that cover almost the entire mitochondrial genome (1 5). Additional MBP were detected when the migration of patient's mtDNA was compared with the migration of the control DNA. With these other probes, however, a comparison of the patient's and the mother's samples revealed no difference between their electrophoretic patterns (data not shown). This suggests that these additional MBP are probably benign polymorphism~.
The 1.1 -kb region of mtDNA corresponding to mitochondrial clone 13 was amplified by PCR from the patient's total DNA, subcloned. and seauenced to determine the specific base changes that account for the MBP. By comparing the sequence of the patient's mtDNA to the published normal human mtDNA sequence (20), an A to G mutation at 15923 was found in the PCR product of the patient's mtDNA (Fig. 3) .
The mutated nt in this patient creates an Ace1 restriction site (GTAAAC to GTAGAC), which provided an easy way to look for the mutation in family members. The mtDNA region corresponding to clone 13 was PCR-amplified from a biochemically normal control, from the mother's twin sister, and from the mother. When the PCR products were digested with AccI, two fragments (829 bp and 309 bp) were generated in the control and maternal relatives, as expected for wild type mtDNA. However, the PCR product amplified from the patient's liver and muscle mtDNA generated an additional 667-bp fragment that is predicted by the mutation, in addition to the wild type 829-bp and 309-bp fragments (Fig. 4A and B) . Another 162-bp fragment predicted by this mutation is presumed to have migrated off the gel. The results in Figure 4A and B confirm heteroplasmy in the patient but gave no reliable quantitative information, because PCR products are not necessarily produced in proportion to mutant and wild type abundance in the native DNA sample.
Around the time that we found this mutation, the mother's twin sister became pregnant and underwent amniocentesis for routine genetic screens in the 1st trimester. Total DNA was isolated from extra cultured amniocytes and also from cells recovered after birth from umbilical cord blood. The 1.1-kb region of mtDNA corresponding to clone 13 was amplified by PCR and directly digested with AccI. As seen in Figure 4C , the total PCR product from the fetal cells generated only two fragments, as expected for wild type mtDNA. Within the limits of detection by these methods, the result suggested that this fetus did not have an A to G mutation at position 15923.
The mutation is located at the last base of the anticodon loop of tRNAth' (Fig. 5A) . The nt sequences of mtDNA from different organisms were aligned to compare conservation of the genes for tRNAthr in the anticodon loop region (Fig. 5B) . Nt A at position 15923 was found to be highly conserved among various eukaryotic mtDNA, suggesting that this nt is functionally very significant. By inspection, the mutation has the potential to lengthen the anticodon stem by as many as 2 additional bp; however, computer analysis of secondary structure, which takes energy considerations into account, revealed that only 1 additional bp is probable. This would reduce the anticodon loop size from 7 to 5 nt.
DISCUSSION
The index case in this family had an A to G mutation at nt 15923 in the tRNAthr gene of liver and muscle mtDNA. The mutation was not detected as a polymorphism among 183 control subjects (21), nor was it present in three asymptomatic maternal relatives. Therefore, the mutation is a strong candidate as the cause of the patient's mitochondrial enzyme deficiency and fatal illness.
Computer analysis of tRNA secondary structure suggests that this mutation will lengthen the anticodon stem by at least 1 bp, thereby reducing the anticodon loop size from 7 to 5 nt. The conformation of a 7-bp anticodon loop is conserved in tRNA of all species, probably for maximum accuracy of the 3-bp codon reading function. It is known that the most conserved regions of a tRNA molecule are the anticodon loop, anticodon stem, the DHU stem, and the aminoacyl acceptor, whereas the T$C and DHU loop and the extra arm are the least conserved (22). Therefore, the mutation at nt 15923 is likely to impair tRNAth' anticodon function, blocking translation with high frequency and resulting in low efficiency of protein synthesis. Respiratory complexes I11 and IV both contain mitochondrial translation products, and enzyme activities involving these respiratory complexes were decreased in the index case, although not uniformly. Complex I11 was affected to a greater extent than complex IV, and both were affected to different extents in different tissues.
It has been shown that aminoacyl tRNA synthetase recognition of its cognate tRNA is extremely specific and can be affected by even a single base change in the tRNA (23). Alterations that change the configuration of the secondary and tertiary structure of the anticodon loop may reduce affinity of the synthetase for the tRNA molecule, but the effect on protein synthesis would depend on the amount of wild type tRNA available for complementation in the same organelle. Another formal possibility is that the mutant tRNAth' could be recognized by the wrong synthetase, thus inserting an inappropriate amino acid into the protein sequence, but this seems unlikely.
Recently, it was reported that 16s rRNA transcriptional termination is severely impaired by a point mutation at nt 3243 in tRNA'eu(UUR) that is associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes, suggesting that an inappropriate ratio of rRNA and mitochondrial protein gene products might be involved in the pathogenesis (24). The mutation in our patient's tRNAthr might similarly affect a proximal controlling region for transcription and/or for mRNA processing in addition to more general effects on translation noted above. Complex I11 was affected more consistently and more severely than complex IV in this patient, possibly because the cytochrome b mRNA is adjacent to tRNAth', which is a processing site in the polycistronic message (25) .
An interesting question is the mechanism by which the tRNA mutation can lead to a variable expression of enzyme deficiency in different tissues. One possible explanation is a variable distribution of mutant mtDNA among mitochondria or among cells, which would result in heterogeneity and a variable complementation effect of wild type tRNA. Intercellular and intracellular heterogeneous populations of mtDNA were found in a patient with fatal infantile mitochondrial myopathy by electron microscopic study (26) . However, with few exceptions, the magnitude of enzyme deficiencies in various tissues is not well correlated with the extent of measurable mtDNA heteroplasmy or even with clinical severity of the mitochondrial disease (5). Qualitatively, heteroplasmy was similar in our patient's liver and muscle, yet the biochemical enzyme deficiency was much greater in muscle, a difference that remains unexplained.
The mother had a normal phenotype; the mutation and respiratory chain deficiency appeared only in her progeny. The identical twin sister in theory could have a dissimilar mitochondrial genotype because of unequal distribution of mitochondria during fission, but neither the patient's mother nor the mother's twin sister had the mutation in somatic tissue (blood). Heteroplasmy in the patient suggests that the detrimental mutation may have existed in the germ line or may have arisen during oogenesis and thereby was inherited from a phenotypically normal mother. Alternatively, it may have arisen during early embryogenesis. The fact that a previous child died with a similar course suggests a defective germ line, because a spontaneous disease is unlikely to have occurred twice. However, without access to mtDNA from this sibling, it is not possible to know if the mutation was present. The comparable degree of heteroplasmy in liver and muscle found in the patient also supports the occurrence of a maternal mutation in the germ line.
Hauswirth and Laipis (27) demonstrated that one genotype of mtDNA could switch completely to another genotype in a single generation because the number of mtDNA in one organelle can be reduced remarkably during oogenesis. If variable heteroplasmy characterizes the mother's germ line, some fetuses could have been more affected than others, contributing to the variable timing of miscarriage. The index case developed normally to full term, perhaps because she had a relatively small proportion of mutant to wild type mtDNA. However, because there is no direct evidence of mtDNA mutation in the mother or her identical twin, it is possible that the frequent history of miscarriages and difficult conception in these women may be due to another familial factor.
%
The extension of mtDNA analysis to amniocytes and umbilical blood cells led to the conclusion that the child of the mother's twin sister does not have the mutation. Although not diagnostic, the result was encouraging for the family because neither of the twin sisters had ever produced a child that survived. However, caution must be exercised in interpreting such results, because mtDNA in cultured amniocytes and blood cells may not be representative of mtDNA in cells of critical fetal organs. Also, a small percentage of heteroplasmy could be missed due to limitations in sensitivity of the methods used to detect mutations. Finally, there is always the possibility that the mutation we found Fig. 4 . Detection of the tRNAth' gene mutation at nt 15923 by AccI digestion. A, The bracketed arrows show that the 1.1-kb PCR amplified fragment from the wild type mtDNA will generate two fragments upon digestion with AccI (top line), whereas the same enzyme digestion of mutant mtDNA will generate three fragments due to the additional AccI site indicated by the verticalarrow at nt 15923 (bottom line). B, Southern blot of AccI-digested PCR products from the liver of a normal control (Cont-L), the blood of the mother's twin sister and the mother, the patient's liver (Ptl-L), and the patient's muscle (Ptl-M). The patient's mtDNA generated a 667-bp fragment predicted by the mutation in addition to the wild type 829-bp fragment. C, Digested PCR products from fetal cells (amniocentesis) and from umbilical cord blood, showing that the mutation was absent. The upper band found in all lanes represents uncut DNA.
in the index case was not the primary cause of illness and death. As of this writing, the twin's child remains healthy.
The patient was the product of uneventful gestation and birth, but she apparently could not sustain independent aerobic metabolism sufficient to meet energy demands after birth. There may be little selection against defective mitochondria during gestation, because fetal tissues are relatively hypoxic, glucose is not limiting, and lactate is cleared by maternal circulation. After birth, aerobic metabolism becomes essential for survival. A recent review considers in detail the special problems that are faced by newborns with mtDNA mutations that cause acute mitochondrial disease in the postnatal period (5). The term infant normally has large carbohydrate stores in liver and heart that are deposited late in
